Fundz

Personal Genome Diagnostics Inc. reported raising $65.4 Million in an initial SEC Form D filing, from an offering of $112 Million

PRIVATEOct 30, 2017$65.4M of $111.5M raised

Amount Raised

$65.4 Million

$65.4 Million sold, per SEC Form D (first sale Oct 30, 2017)

Round Type

Venture

MarylandBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Personal Genome Diagnostics Inc. that raised within 45 days of this round, from Fundz verified event records.

  • GT Medical Technologies raised $53M on December 14, 2017.
  • Koligo Therapeutics, Inc. raised $5K (Pre-Seed) on December 14, 2017.
  • BRIO DEVICE LLC raised $1.3M (Seed) on December 14, 2017.
  • MenoGeniX, Inc. raised $75K (Pre-Seed) on December 14, 2017.
  • Cleveland Diagnostics raised an undisclosed amount on December 13, 2017.
  • Rain Therapeutics Inc. raised $1M (Seed) on December 13, 2017.

Who to call at Personal Genome Diagnostics Inc., and when

A new round usually means Personal Genome Diagnostics Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Personal Genome Diagnostics Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Personal Genome Diagnostics Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Personal Genome Diagnostics Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Personal Genome Diagnostics Inc.

Location

Maryland, United States

About

Personal Genome Diagnostics Inc. develops patient-specific analysis of the cancer genome by using advanced tools and technologies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Personal Genome Diagnostics Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsJay F., Vp Business DevelopmentSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Personal Genome Diagnostics Inc.'s next move

See what Strategic adds

Personal Genome Diagnostics Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.